D
086450
vs
JNJ
D
086450
JNJ
Over the past 12 months, Dongkook Pharmaceutical Co Ltd has outperformed JNJ, delivering a return of +64% compared to the JNJ's +55% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
086450
JNJ
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Dongkook Pharmaceutical Co Ltd Intrinsic Value
LOCKED
JNJ Intrinsic Value
LOCKED
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
|
25 150
KRW
|
|||||
|
Johnson & Johnson
NYSE:JNJ
|
237.96
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
086450, JNJ
086450, JNJ
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
D
|
Dongkook Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
Johnson & Johnson
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
086450, JNJ
086450, JNJ
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
D
|
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
|
|||||||||
|
|
Johnson & Johnson
NYSE:JNJ
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Dongkook Pharmaceutical Co Ltd
53.9%
JNJ
67.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
Operating Margin
Dongkook Pharmaceutical Co Ltd
9.9%
JNJ
34.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
Net Margin
Dongkook Pharmaceutical Co Ltd
6.8%
JNJ
28.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
FCF Margin
Dongkook Pharmaceutical Co Ltd
4.3%
JNJ
20.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROE
Dongkook Pharmaceutical Co Ltd
9.9%
JNJ
35.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROA
Dongkook Pharmaceutical Co Ltd
6.2%
JNJ
14.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROIC
Dongkook Pharmaceutical Co Ltd
8.4%
JNJ
17.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
ROCE
Dongkook Pharmaceutical Co Ltd
12.1%
JNJ
24.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
Dongkook Pharmaceutical Co Ltd | ||||
|
|
Johnson & Johnson | ||||
Solvency Comparison
D
Dongkook Pharmaceutical Co Ltd
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
086450, JNJ
086450, JNJ
Performance Gap
086450, JNJ
086450, JNJ
Performance Gap Between 086450 and JNJ
LOCKED
Performance By Year
086450, JNJ
086450, JNJ
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 086450 to other stocks
LLY
Eli Lilly and Co
More expensive
vs Dongkook Pharmaceutical Co Ltd
ROG
Roche Holding AG
Cheaper
vs Dongkook Pharmaceutical Co Ltd
AZN
AstraZeneca PLC
More expensive
vs Dongkook Pharmaceutical Co Ltd
MRK
Merck & Co Inc
More expensive
vs Dongkook Pharmaceutical Co Ltd
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
